VONPLAZE Trademark

Trademark Overview


On Friday, September 15, 2023, a trademark application was filed for VONPLAZE with the United States Patent and Trademark Office. The USPTO has given the VONPLAZE trademark a serial number of 79381907. The federal status of this trademark filing is REGISTERED as of Tuesday, March 26, 2024. This trademark is owned by Novartis AG. The VONPLAZE trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
vonplaze

General Information


Serial Number79381907
Word MarkVONPLAZE
Filing DateFriday, September 15, 2023
Status700 - REGISTERED
Status DateTuesday, March 26, 2024
Registration Number7334266
Registration DateTuesday, March 26, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 7, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events


Event DateEvent Description
Thursday, October 26, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, October 31, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, November 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 11, 2023APPLICATION FILING RECEIPT MAILED
Monday, December 4, 2023ASSIGNED TO EXAMINER
Tuesday, December 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 12, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 12, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 12, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 12, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 12, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, December 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, March 26, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, April 25, 2024GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Monday, April 29, 2024FINAL DISPOSITION NOTICE SENT TO IB
Monday, April 29, 2024FINAL DISPOSITION PROCESSED
Monday, May 20, 2024NOTIFICATION PROCESSED BY IB
Tuesday, March 25, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, March 25, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Saturday, April 12, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB